Andres Ricaurte Fajardo: How dural-based metastases can be distinguished from meningioma

Andres Ricaurte Fajardo, Molecular Imaging and Theranostics Researcher at Weil Cornell Medicine, shared a post on X:

“Thrilled to be part of this study highlighting how dural-based metastases rare yet significant in prostate cancer can be distinguished from meningioma, using Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET). This underscores the value of targeted PET in Prostate Cancer.
Congratulations Divya Yadav, Jana Ivanidze.”

PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer published in ScienceDirect.

Authors: Divya Yadav, Silvina P. Dutruel, Elisabeth O’Dwyer, Andres Ricaurte Fajardo, Rituraj Upadhyay, Joshua D. Palmer, Susan C. Pannullo, Scott T. Tagawa, Jonathan P.S. Knisely, Andrew Brandmaier, Joseph R. Osborne, Jana Ivanidze.

Additional information
Source: Andres Ricaurte Fajardo/X